The proliferation of irrational metformin fixed-dose combinations in India

被引：9
|
作者：
Evans, Valerie [1 ]
Pollock, Allyson M. [2 ]
机构：
[1] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland
[2] Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2015年 / 3卷 / 02期
关键词：
D O I：
10.1016/S2213-8587(14)70239-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：98 / 100
页数：4
相关论文
共 50 条
  • [21] Fixed-dose combinations for emerging treatment of pain
    Raffa, Robert B.
    Tallarida, Ronald J.
    Taylor, Robert, Jr.
    Pergolizzi, Joseph V., Jr.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1261 - 1270
  • [22] Fixed-dose combinations: An essential for rational preparation
    Thangaraju, Pugazhenthan
    Varthya, Shoban Babu
    Venkatesan, Sajitha
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (02) : 170 - 172
  • [23] Fixed-dose single tablet antidiabetic combinations
    Bailey, C. J.
    Day, C.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 527 - 533
  • [24] From combined therapy to fixed-dose combinations
    Kolos, I. P.
    Boytsov, S. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (04): : 89 - 94
  • [25] India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
    Sulis, Giorgia
    Pradhan, Richeek
    Kotwani, Anita
    Gandra, Sumanth
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [26] Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
    Brhlikova, Petra
    Mehta, Aashna
    McGettigan, Patricia
    Pollock, Allyson M.
    Roderick, Peter
    Farooqui, Habib Hasan
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [27] Fixed-dose combinations banned in India: is it the right decision? An eye-opening review
    Miranda, Marlon Ramcy Henry
    Dubey, Akhilesh
    Ravi, G. S.
    Charyulu, R. Narayana
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (10) : 977 - 985
  • [28] India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
    Giorgia Sulis
    Richeek Pradhan
    Anita Kotwani
    Sumanth Gandra
    Journal of Pharmaceutical Policy and Practice, 15
  • [29] Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
    Petra Brhlikova
    Aashna Mehta
    Patricia McGettigan
    Allyson M. Pollock
    Peter Roderick
    Habib Hasan Farooqui
    Journal of Pharmaceutical Policy and Practice, 16
  • [30] Treatment adherence: can fixed-dose combinations help?
    不详
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02): : 91 - 91
12345